Copyright Reports & Markets. All rights reserved.

Global Genomic Biomarkers Market Size, Status and Forecast 2020-2026

Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Genomic Biomarkers Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Genomic Biomarkers Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Oncology
    • 1.4.3 Cardiovascular diseases
    • 1.4.4 Neurological diseases
    • 1.4.5 Others
  • 1.5 Market by Application
    • 1.5.1 Global Genomic Biomarkers Market Share by Application: 2020 VS 2026
    • 1.5.2 Diagnostic and research laboratories
    • 1.5.3 Hospitals
    • 1.5.4 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Genomic Biomarkers Market Perspective (2015-2026)
  • 2.2 Global Genomic Biomarkers Growth Trends by Regions
    • 2.2.1 Genomic Biomarkers Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Genomic Biomarkers Historic Market Share by Regions (2015-2020)
    • 2.2.3 Genomic Biomarkers Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Genomic Biomarkers Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Genomic Biomarkers Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Genomic Biomarkers Players by Market Size
    • 3.1.1 Global Top Genomic Biomarkers Players by Revenue (2015-2020)
    • 3.1.2 Global Genomic Biomarkers Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Genomic Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Genomic Biomarkers Market Concentration Ratio
    • 3.2.1 Global Genomic Biomarkers Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Genomic Biomarkers Revenue in 2019
  • 3.3 Genomic Biomarkers Key Players Head office and Area Served
  • 3.4 Key Players Genomic Biomarkers Product Solution and Service
  • 3.5 Date of Enter into Genomic Biomarkers Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Genomic Biomarkers Historic Market Size by Type (2015-2020)
  • 4.2 Global Genomic Biomarkers Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Genomic Biomarkers Market Size by Application (2015-2020)
  • 5.2 Global Genomic Biomarkers Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Genomic Biomarkers Market Size (2015-2020)
  • 6.2 Genomic Biomarkers Key Players in North America (2019-2020)
  • 6.3 North America Genomic Biomarkers Market Size by Type (2015-2020)
  • 6.4 North America Genomic Biomarkers Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Genomic Biomarkers Market Size (2015-2020)
  • 7.2 Genomic Biomarkers Key Players in Europe (2019-2020)
  • 7.3 Europe Genomic Biomarkers Market Size by Type (2015-2020)
  • 7.4 Europe Genomic Biomarkers Market Size by Application (2015-2020)

8 China

  • 8.1 China Genomic Biomarkers Market Size (2015-2020)
  • 8.2 Genomic Biomarkers Key Players in China (2019-2020)
  • 8.3 China Genomic Biomarkers Market Size by Type (2015-2020)
  • 8.4 China Genomic Biomarkers Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Genomic Biomarkers Market Size (2015-2020)
  • 9.2 Genomic Biomarkers Key Players in Japan (2019-2020)
  • 9.3 Japan Genomic Biomarkers Market Size by Type (2015-2020)
  • 9.4 Japan Genomic Biomarkers Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Genomic Biomarkers Market Size (2015-2020)
  • 10.2 Genomic Biomarkers Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Genomic Biomarkers Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Genomic Biomarkers Market Size by Application (2015-2020)

11 India

  • 11.1 India Genomic Biomarkers Market Size (2015-2020)
  • 11.2 Genomic Biomarkers Key Players in India (2019-2020)
  • 11.3 India Genomic Biomarkers Market Size by Type (2015-2020)
  • 11.4 India Genomic Biomarkers Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Genomic Biomarkers Market Size (2015-2020)
  • 12.2 Genomic Biomarkers Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Genomic Biomarkers Market Size by Type (2015-2020)
  • 12.4 Central & South America Genomic Biomarkers Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Thermo Fisher Scientific
    • 13.1.1 Thermo Fisher Scientific Company Details
    • 13.1.2 Thermo Fisher Scientific Business Overview
    • 13.1.3 Thermo Fisher Scientific Genomic Biomarkers Introduction
    • 13.1.4 Thermo Fisher Scientific Revenue in Genomic Biomarkers Business (2015-2020))
    • 13.1.5 Thermo Fisher Scientific Recent Development
  • 13.2 Roche
    • 13.2.1 Roche Company Details
    • 13.2.2 Roche Business Overview
    • 13.2.3 Roche Genomic Biomarkers Introduction
    • 13.2.4 Roche Revenue in Genomic Biomarkers Business (2015-2020)
    • 13.2.5 Roche Recent Development
  • 13.3 Aepodia
    • 13.3.1 Aepodia Company Details
    • 13.3.2 Aepodia Business Overview
    • 13.3.3 Aepodia Genomic Biomarkers Introduction
    • 13.3.4 Aepodia Revenue in Genomic Biomarkers Business (2015-2020)
    • 13.3.5 Aepodia Recent Development
  • 13.4 Myriad Genetics
    • 13.4.1 Myriad Genetics Company Details
    • 13.4.2 Myriad Genetics Business Overview
    • 13.4.3 Myriad Genetics Genomic Biomarkers Introduction
    • 13.4.4 Myriad Genetics Revenue in Genomic Biomarkers Business (2015-2020)
    • 13.4.5 Myriad Genetics Recent Development
  • 13.5 Eurofins Scientific
    • 13.5.1 Eurofins Scientific Company Details
    • 13.5.2 Eurofins Scientific Business Overview
    • 13.5.3 Eurofins Scientific Genomic Biomarkers Introduction
    • 13.5.4 Eurofins Scientific Revenue in Genomic Biomarkers Business (2015-2020)
    • 13.5.5 Eurofins Scientific Recent Development
  • 13.6 QIAGEN
    • 13.6.1 QIAGEN Company Details
    • 13.6.2 QIAGEN Business Overview
    • 13.6.3 QIAGEN Genomic Biomarkers Introduction
    • 13.6.4 QIAGEN Revenue in Genomic Biomarkers Business (2015-2020)
    • 13.6.5 QIAGEN Recent Development
  • 13.7 Bio-Rad Laboratories
    • 13.7.1 Bio-Rad Laboratories Company Details
    • 13.7.2 Bio-Rad Laboratories Business Overview
    • 13.7.3 Bio-Rad Laboratories Genomic Biomarkers Introduction
    • 13.7.4 Bio-Rad Laboratories Revenue in Genomic Biomarkers Business (2015-2020)
    • 13.7.5 Bio-Rad Laboratories Recent Development
  • 13.8 Genomic Health
    • 13.8.1 Genomic Health Company Details
    • 13.8.2 Genomic Health Business Overview
    • 13.8.3 Genomic Health Genomic Biomarkers Introduction
    • 13.8.4 Genomic Health Revenue in Genomic Biomarkers Business (2015-2020)
    • 13.8.5 Genomic Health Recent Development
  • 13.9 Liquid Genomics
    • 13.9.1 Liquid Genomics Company Details
    • 13.9.2 Liquid Genomics Business Overview
    • 13.9.3 Liquid Genomics Genomic Biomarkers Introduction
    • 13.9.4 Liquid Genomics Revenue in Genomic Biomarkers Business (2015-2020)
    • 13.9.5 Liquid Genomics Recent Development
  • 13.10 Epigenomics
    • 13.10.1 Epigenomics Company Details
    • 13.10.2 Epigenomics Business Overview
    • 13.10.3 Epigenomics Genomic Biomarkers Introduction
    • 13.10.4 Epigenomics Revenue in Genomic Biomarkers Business (2015-2020)
    • 13.10.5 Epigenomics Recent Development
  • 13.11 AROS Applied Biotechnology
    • 10.11.1 AROS Applied Biotechnology Company Details
    • 10.11.2 AROS Applied Biotechnology Business Overview
    • 10.11.3 AROS Applied Biotechnology Genomic Biomarkers Introduction
    • 10.11.4 AROS Applied Biotechnology Revenue in Genomic Biomarkers Business (2015-2020)
    • 10.11.5 AROS Applied Biotechnology Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Genomic Biomarkers market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Genomic Biomarkers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Thermo Fisher Scientific
    Roche
    Aepodia
    Myriad Genetics
    Eurofins Scientific
    QIAGEN
    Bio-Rad Laboratories
    Genomic Health
    Liquid Genomics
    Epigenomics
    AROS Applied Biotechnology

    Market segment by Type, the product can be split into
    Oncology
    Cardiovascular diseases
    Neurological diseases
    Others
    Market segment by Application, split into
    Diagnostic and research laboratories
    Hospitals
    Others

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now